跳至主要内容
临床试验/JPRN-UMIN000003712
JPRN-UMIN000003712已完成2 期

A Phase II Study of Pemetrexed and EGFR-TKI in Patients with Non-Small Cell Lung Cancer After Failing EGFR-TKIs - A Phase II Study of Pemetrexed and EGFR-TKI in Patients with Non-Small Cell Lung Cancer After Failing EGFR-TKIs

Osaka Lung Cancer Study Group0 个研究点目标入组 25 人开始时间: 2010年6月7日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Using NSAIDs regularly. 2) Interstitial pneumonia/lung fibrosis on chest CT. 3) Previous drug allergy 4) History of poorly controlled pleural effusion, pericardial effusion and ascites. 5) Active infection. 6) Current Diarrhea. 7) Ileus or intestinal tract paralysis. 8) Symptomatic brain metastasis. 9) Active concomitant malignancy. 10) History of sever heart disease. 11) History of sever psychological disease. 12) Hoped to be pregnant/nursing. 13) Those judged to be not suitable by the attending physician.

研究者

发起方
Osaka Lung Cancer Study Group

相似试验